United States & Medtronic

United States: Part of North American Cobalt Inc., the largest regional market with 38.5% share.

Medtronic: Listed as a key player; expected to benefit from market growth.

United States: Beluga Medical, one of the companies Medtronic invested in, is located in California, United States. The Sphere-9 catheter is approved in the U.S., and the Sphere-360 catheter is investigational in the United States.

Medtronic: Medtronic made strategic investments in two privately held companies to enhance its cardiac ablation business and integrate intracardiac echocardiography (ICE) into its Affera mapping and ablation system, aiming to strengthen its leadership in electrophysiology.

United States: The United States is involved in a fragile ceasefire with Iran, which is being tested by recent attacks. The US military has downed Iranian drones and launched retaliatory strikes, indicating direct involvement in the conflict.

Medtronic: Medtronic climbed after reporting a stronger profit and increasing its dividend payout, indicating positive financial performance.

United States: US regulators may investigate the breach and enforce data protection laws, potentially imposing fines on Amgen.

Medtronic: Mentioned as one of the healthcare companies recently affected by cyberattacks, highlighting sector-wide vulnerability.

Medtronic: Medtronic formed a strategic partnership with SOMNOmedics to integrate sleep monitoring data into its chronic disease digital health ecosystem.